Belmont Capital’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-260,000
| Closed | -$770K | – | 169 |
|
|
2024
Q2 | $770K | Hold |
260,000
| – | – | 0.14% | 55 |
|
|
2024
Q1 | $1.18M | Sell |
260,000
-250,000
| -49% | -$1.13M | 0.32% | 32 |
|
|
2023
Q4 | $2.91M | Hold |
510,000
| – | – | 1.24% | 12 |
|
|
2023
Q3 | $2.35M | Hold |
510,000
| – | – | 1.27% | 11 |
|
|
2023
Q2 | $3.29M | Hold |
510,000
| – | – | 1.85% | 11 |
|
|
2023
Q1 | $3.85M | Hold |
510,000
| – | – | 3.18% | 8 |
|
|
2022
Q4 | $5.17M | Hold |
510,000
| – | – | 5.53% | 6 |
|
|
2022
Q3 | $5.04M | Buy |
510,000
+460,000
| +920% | +$4.55M | 5.95% | 5 |
|
|
2022
Q2 | $533K | Sell |
50,000
-50,000
| -50% | -$533K | 0.65% | 15 |
|
|
2022
Q1 | $975K | Sell |
100,000
-50,000
| -33% | -$488K | 0.97% | 7 |
|
|
2021
Q4 | $2.15M | Hold |
150,000
| – | – | 1.68% | 8 |
|
|
2021
Q3 | $3.01M | Hold |
150,000
| – | – | 2.44% | 6 |
|
|
2021
Q2 | $3.3M | Buy |
+150,000
| New | +$3.3M | 3.4% | 5 |
|